|
US7365093B2
(en)
*
|
1994-08-19 |
2008-04-29 |
Abbott Laboratories |
Endothelin antagonists
|
|
GB0004297D0
(en)
*
|
2000-02-23 |
2000-04-12 |
Ucb Sa |
2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
|
|
US6686477B2
(en)
|
2000-09-29 |
2004-02-03 |
Eastman Chemical Company |
Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
|
|
WO2002067931A1
(en)
*
|
2001-02-23 |
2002-09-06 |
Johns Hopkins University |
Treatment of tics, tremors and related disorders
|
|
JP4334344B2
(ja)
*
|
2001-08-10 |
2009-09-30 |
ユセベ ファルマ ソシエテ アノニム |
オキソピロリジン化合物、当該化合物の調製、並びにレベチラセタム及び類似体の製造におけるその化合物の使用
|
|
DE60218193T2
(de)
*
|
2001-10-08 |
2007-11-22 |
Ucb S.A. |
Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia
|
|
WO2003032981A1
(en)
|
2001-10-16 |
2003-04-24 |
Memory Pharmaceuticals Corporation |
4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
|
|
AU2003242538A1
(en)
*
|
2002-05-14 |
2003-11-11 |
Ucb, S.A. |
Use of 2-oxo-1-pyrrolidone derivatives for the preparation of a drug
|
|
DE602004023051D1
(de)
*
|
2003-01-13 |
2009-10-22 |
Ucb Pharma Sa |
Hydrierungskatalysatoren
|
|
CN1802352A
(zh)
*
|
2003-02-03 |
2006-07-12 |
特瓦制药工业有限公司 |
制备左乙拉西坦的方法
|
|
ES2214147B1
(es)
|
2003-02-28 |
2005-10-01 |
Farma-Lepori S.A. |
Procedimiento de obtencion de un agente antiepileptico.
|
|
TR200503397T1
(tr)
*
|
2003-03-18 |
2007-03-21 |
Hetero Drugs Limited |
Levetirasetam'ın yeni kristal formları.
|
|
RU2232578C1
(ru)
*
|
2003-04-10 |
2004-07-20 |
Ахапкина Валентина Ивановна |
Вещество, обладающее антидепрессивной активностью
|
|
US7696198B2
(en)
|
2003-04-16 |
2010-04-13 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors
|
|
US7034051B2
(en)
*
|
2003-08-28 |
2006-04-25 |
Adolor Corporation |
Fused bicyclic carboxamide derivatives and methods of their use
|
|
WO2005023763A1
(en)
*
|
2003-09-05 |
2005-03-17 |
Ranbaxy Laboratories Limited |
Process for the preparation of pure levetiracetam
|
|
EP1667967B1
(en)
*
|
2003-09-24 |
2012-08-01 |
UCB Pharma, S.A. |
Process for preparing 2-oxo-1-pyrrolidine derivatives
|
|
CA2546970C
(en)
|
2003-12-02 |
2011-04-26 |
Ucb, S.A. |
Imidazole derivatives, processes for preparing them and their uses
|
|
CN1964942A
(zh)
*
|
2004-06-11 |
2007-05-16 |
Ucb股份有限公司 |
通过分子内烯丙基化制备2－氧代－1－吡咯烷衍生物的方法
|
|
CN1972904B
(zh)
*
|
2004-06-21 |
2011-02-02 |
沃尼尔·朗伯有限责任公司 |
普瑞巴林和相关化合物的制备
|
|
US7427601B2
(en)
*
|
2004-06-24 |
2008-09-23 |
Schwarz Pharma Ag |
Method for treating tremor
|
|
WO2006044955A1
(en)
*
|
2004-10-20 |
2006-04-27 |
Memory Pharmaceuticals Corporation |
Phosphodiesterase 4 inhibitors
|
|
CA2488325C
(en)
*
|
2004-11-22 |
2010-08-24 |
Apotex Pharmachem Inc. |
Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
|
|
US8178533B2
(en)
|
2005-06-01 |
2012-05-15 |
Ucb Pharma, S.A. |
2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
|
|
EP1731149A1
(en)
*
|
2005-06-08 |
2006-12-13 |
Ucb S.A. |
Use of 2-oxo-1-pyrrolidone derivatives for the treatment of diseases characterized by progressive myoclonic epilepsy
|
|
CN101263113B
(zh)
*
|
2005-09-15 |
2012-06-13 |
Ucb医药有限公司 |
4-取代的-吡咯烷-2-酮及其用途
|
|
JP2007153755A
(ja)
*
|
2005-12-01 |
2007-06-21 |
Gifu Univ |
プロリン類縁体
|
|
US8076493B2
(en)
*
|
2005-12-07 |
2011-12-13 |
Ucb Pharma, S.A. |
3-carboxy-2-oxo-1-pyrrolidine derivatives and their uses
|
|
US8338621B2
(en)
|
2005-12-21 |
2012-12-25 |
Ucb S.A. |
Process for the preparation of 2-oxo-1-pyrrolidine derivatives
|
|
LV13630B
(en)
*
|
2006-03-16 |
2007-12-20 |
Olainfarm As |
Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
|
|
EP2041084B1
(en)
*
|
2006-06-08 |
2013-11-06 |
UCB Pharma, S.A. |
Co-crystals of pyrrolidinones
|
|
EA019757B1
(ru)
*
|
2006-06-15 |
2014-06-30 |
ЮСиБи ФАРМА ГМБХ |
Фармацевтическая композиция с синергетическим противосудорожным эффектом
|
|
EP2051696A2
(en)
*
|
2006-08-18 |
2009-04-29 |
Morton Grove Pharmaceuticals, Inc. |
Stable liquid levetiracetam compositions and methods
|
|
GEP20125425B
(en)
*
|
2006-10-18 |
2012-03-26 |
Pfizer Prod Inc |
Biaryl ether urea compounds
|
|
US8828665B2
(en)
|
2007-02-16 |
2014-09-09 |
Ark Diagnostics, Inc. |
Compounds and methods for use in detecting gabapentin
|
|
EP2152262A2
(en)
*
|
2007-04-27 |
2010-02-17 |
UCB Pharma, S.A. |
New heterocyclic derivatives useful for the treatment of cns disorders
|
|
US20090082422A1
(en)
*
|
2007-09-26 |
2009-03-26 |
Protia, Llc |
Deuterium-enriched levetiracetam
|
|
DK2273975T3
(da)
*
|
2008-03-03 |
2014-06-30 |
Ucb Pharma Sa |
Farmaceutiske opløsninger, fremgangsmåde til fremstilling og terapeutiske anvendelser
|
|
US7741327B2
(en)
*
|
2008-04-16 |
2010-06-22 |
Hoffmann-La Roche Inc. |
Pyrrolidinone glucokinase activators
|
|
WO2010002869A1
(en)
*
|
2008-07-01 |
2010-01-07 |
Concert Pharmaceuticals, Inc. |
2-oxo-1-pyrrolidine derivatives
|
|
EP2147911A1
(en)
|
2008-07-24 |
2010-01-27 |
ZaCh System S.p.A. |
Process for the preparation of levetiracetam
|
|
JP4644881B2
(ja)
*
|
2008-09-19 |
2011-03-09 |
高砂香料工業株式会社 |
ルテニウム錯体の製造方法
|
|
EP2346500B1
(en)
|
2008-10-16 |
2017-05-17 |
The Johns Hopkins University |
Methods and compositions for improving cognitive function
|
|
US8168756B2
(en)
|
2008-10-24 |
2012-05-01 |
Ark Diagnostics, Inc. |
Levetiracetam immunoassays
|
|
WO2010054009A1
(en)
*
|
2008-11-07 |
2010-05-14 |
Novabay Pharmaceuticals, Inc. |
Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions
|
|
KR101788804B1
(ko)
*
|
2008-11-18 |
2017-10-20 |
유씨비 파마, 에스.에이. |
２―옥소―１―피롤리딘 유도체를 포함하는 연장 방출 제형
|
|
KR101689688B1
(ko)
*
|
2008-11-18 |
2016-12-26 |
유씨비 파마, 에스.에이. |
２옥소１피롤리딘 유도체를 포함하는 지연 방출형 제형
|
|
FR2939311A1
(fr)
*
|
2008-12-08 |
2010-06-11 |
Oreal |
Utilisation d'un derive diester de pyrrolidinone 4-carboxy comme solvant dans les compositions cosmetiques ; compositions cosmetiques les contenant
|
|
EP2393483B1
(en)
|
2009-02-09 |
2017-06-28 |
UCB Biopharma SPRL |
Pharmaceutical compositions comprising brivaracetam
|
|
US8846411B2
(en)
*
|
2009-06-11 |
2014-09-30 |
Microgenics Corporation |
Derivatives, reagents, and immunoassay for detecting levetiracetam
|
|
WO2011015349A2
(en)
|
2009-08-07 |
2011-02-10 |
Ucb Pharma, S.A. |
Methods for enhancing the cognitive function
|
|
US7939676B2
(en)
|
2009-09-17 |
2011-05-10 |
Zach System S.P.A. |
Process for the preparation of levetiracetam
|
|
US8487591B1
(en)
|
2009-12-31 |
2013-07-16 |
Cirrus Logic, Inc. |
Power control system with power drop out immunity and uncompromised startup time
|
|
PL389364A1
(pl)
|
2009-10-23 |
2011-04-26 |
Uniwersytet Jagielloński |
Nowe zastosowanie pochodnych 2-pirolidonu
|
|
TW201118103A
(en)
|
2009-10-23 |
2011-06-01 |
Ucb Pharma Sa |
2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
|
|
EP2533645B1
(en)
|
2010-02-09 |
2016-07-27 |
The Johns Hopkins University |
Methods and compositions for improving cognitive function
|
|
FR2961098A1
(fr)
|
2010-06-09 |
2011-12-16 |
Oreal |
Composition comprenant au moins une 2-pyrrolidone fonctionnalisee en position 4 par un acide carboxylique ou amide, et au moins un colorant direct ou un pigment pour la teinture des fibres keratiniques
|
|
FR2961101B1
(fr)
|
2010-06-09 |
2013-01-25 |
Oreal |
Composition comprenant au moins une 2-pyrrolidone fonctionnalisee par un radical ester ou amide, et au moins un pigment ou un colorant direct pour la teinture des matieres keratiniques
|
|
FR2961099B1
(fr)
|
2010-06-09 |
2012-06-15 |
Oreal |
Derives de 2-pyrrolidone fonctionnalisee par un radical ester, acide ou amide, la composition cosmetique les comprenant et leur utilisation pour le conditionnement des matieres keratiniques
|
|
US8466297B2
(en)
|
2010-11-01 |
2013-06-18 |
Milan Soukup |
Manufacturing process for (S)-Pregabalin
|
|
AU2011328993B2
(en)
|
2010-11-15 |
2017-03-02 |
Agenebio, Inc. |
Pyridazine derivatives, compositions and methods for treating cognitive impairment
|
|
EP2672822A4
(en)
*
|
2011-02-09 |
2014-08-27 |
Univ Johns Hopkins |
METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTIONS
|
|
PL2699581T3
(pl)
|
2011-04-18 |
2016-05-31 |
Ucb Biopharma Sprl |
Pochodne 2-okso-1-imidazolidynyloimidazotiadiazolu
|
|
JP6162125B2
(ja)
|
2011-09-30 |
2017-07-12 |
タフツ・ユニバーシティ |
神経変性障害を処置するためのウリジン二リン酸誘導体、組成物および方法
|
|
RU2632659C2
(ru)
*
|
2011-12-27 |
2017-10-09 |
Байо-Фарм Солюшнс Ко., Лтд. |
Фенилкарбаматные соединения для применения в предупреждении или лечении эпилепсии
|
|
TW201408293A
(zh)
*
|
2012-07-05 |
2014-03-01 |
Merz Pharma Gmbh & Co Kgaa |
(r)-苯基披喇瑟盪於治療疾病相關疲勞之用途
|
|
TW201408294A
(zh)
*
|
2012-07-05 |
2014-03-01 |
Merz Pharma Gmbh & Co Kgaa |
(r)-苯基披喇瑟盪於治療帕金森氏症之用除
|
|
US9163055B2
(en)
|
2012-09-28 |
2015-10-20 |
Tufts University |
Methods for treating glaucoma using uridine diphosphate derivatives
|
|
US10154988B2
(en)
|
2012-11-14 |
2018-12-18 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
|
DK2928865T3
(en)
|
2012-12-07 |
2018-06-18 |
Merck Sharp & Dohme |
BIOCATALYTIC TRANSAMINATION PROCEDURE
|
|
WO2014087367A2
(en)
*
|
2012-12-09 |
2014-06-12 |
Mahesh Kandula |
Compositions and methods for the treatment of neurological diseases and its associated complications
|
|
WO2014113717A1
(en)
|
2013-01-18 |
2014-07-24 |
Ark Diagnostics, Inc. |
Voriconazole immunoassays
|
|
WO2014126861A1
(en)
|
2013-02-13 |
2014-08-21 |
Ark Diagnostics, Inc. |
Posaconazole immunoassays
|
|
PL2968385T3
(pl)
|
2013-03-13 |
2019-05-31 |
Univ Tufts |
Pochodne nukleozydów urydynowych, kompozycje i sposoby zastosowania
|
|
US10138265B2
(en)
|
2013-03-13 |
2018-11-27 |
Tufts University |
Uridine nucleoside derivatives, compositions and methods of use
|
|
US10806717B2
(en)
|
2013-03-15 |
2020-10-20 |
The Johns Hopkins University |
Methods and compositions for improving cognitive function
|
|
CN103342672B
(zh)
*
|
2013-07-02 |
2015-12-23 |
扬州大学 |
取代吡咯烷-2-酮的新合成方法
|
|
JP6465634B2
(ja)
*
|
2013-12-05 |
2019-02-06 |
株式会社日本触媒 |
環状アミド基含有重合体
|
|
JP6453632B2
(ja)
*
|
2013-12-05 |
2019-01-16 |
株式会社日本触媒 |
環状アミドアクリレート含有組成物およびその製造方法
|
|
EP4032889B1
(en)
|
2013-12-20 |
2026-05-06 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
ME03518B
(me)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
|
|
PL3096790T3
(pl)
|
2014-01-21 |
2020-01-31 |
Janssen Pharmaceutica, N.V. |
Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
|
|
CN104098497B
(zh)
*
|
2014-06-17 |
2016-04-13 |
王庚禹 |
一种新的酰胺类化合物
|
|
WO2016075082A1
(en)
|
2014-11-10 |
2016-05-19 |
Sandoz Ag |
Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam
|
|
WO2016131947A1
(en)
|
2015-02-20 |
2016-08-25 |
Ucb Biopharma Sprl |
Combination treatment
|
|
CN108689968B
(zh)
*
|
2015-05-25 |
2020-09-15 |
苏州鹏旭医药科技有限公司 |
两种化合物及其制备方法和在合成布瓦西坦中的用途
|
|
CN106365986B
(zh)
*
|
2015-07-21 |
2019-01-08 |
苏州鹏旭医药科技有限公司 |
化合物及其制备方法和在合成布瓦西坦中的用途
|
|
JP6872500B2
(ja)
|
2015-05-25 |
2021-05-19 |
エステベ・キミカ・ソシエダッド・アノニマＥｓｔｅｖｅ Ｑｕｉｍｉｃａ， Ｓ．Ａ． |
ブリバラセタムを製造する方法
|
|
US11384104B2
(en)
|
2015-06-19 |
2022-07-12 |
Centurion Biopharma Corporation |
Delivery systems for controlled drug release
|
|
EP3310785B1
(en)
|
2015-06-19 |
2024-11-20 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
WO2017076737A1
(en)
|
2015-11-03 |
2017-05-11 |
Ucb Biopharma Sprl |
Continuous process for preparing brivaracetam
|
|
HRP20211518T1
(hr)
|
2015-11-03 |
2021-12-24 |
UCB Biopharma SRL |
Postupak priprave brivaracetama
|
|
CN106748748B
(zh)
*
|
2015-11-10 |
2021-08-24 |
成都国为生物医药有限公司 |
一种布瓦西坦的制备方法及其中间体
|
|
EP3397253A1
(en)
|
2015-12-30 |
2018-11-07 |
Adamas Pharmaceuticals, Inc. |
Methods and compositions for the treatment of seizure-related disorders
|
|
CN105646319B
(zh)
*
|
2015-12-30 |
2018-05-18 |
佛山市隆信医药科技有限公司 |
一种布瓦西坦的制备方法
|
|
EP3452447A4
(en)
|
2016-05-03 |
2019-12-18 |
The Regents of The University of California |
INHIBITORS OF IRES-MEDIATED PROTEIN SYNTHESIS
|
|
RU2629117C1
(ru)
*
|
2016-06-14 |
2017-08-24 |
Сизов Владимир Владимирович |
Способ получения 4-замещенного 2-[2-оксо-1-пирролидинил] ацетамида
|
|
CN107513031B
(zh)
*
|
2016-06-16 |
2022-08-02 |
上海医药集团股份有限公司 |
一种2-氧代-1-吡咯烷手性衍生物的制备方法
|
|
US20180170941A1
(en)
|
2016-12-19 |
2018-06-21 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
WO2018136792A1
(en)
|
2017-01-20 |
2018-07-26 |
The Regents Of The University Of California |
Inhibitors of the n-terminal domain of the androgen receptor
|
|
CN106866483A
(zh)
*
|
2017-02-05 |
2017-06-20 |
苏州鹏旭医药科技有限公司 |
布瓦西坦的晶型c及其制备方法
|
|
WO2018141276A1
(zh)
*
|
2017-02-05 |
2018-08-09 |
苏州鹏旭医药科技有限公司 |
布瓦西坦中间体的晶型a及其制备方法和布瓦西坦的晶型c及其制备方法
|
|
CN108503610B
(zh)
|
2017-02-24 |
2019-09-13 |
北京艾百诺医药股份有限公司 |
一种光学纯的(r)-4-正丙基-二氢呋喃-2(3h)-酮的制备方法
|
|
CN108658831B
(zh)
*
|
2017-03-30 |
2021-11-05 |
江苏豪森药业集团有限公司 |
2-氧代-1-吡咯烷衍生物或其盐的制备方法
|
|
WO2018200517A1
(en)
|
2017-04-24 |
2018-11-01 |
Tesaro, Inc. |
Methods of manufacturing of niraparib
|
|
IL321754A
(en)
|
2017-06-30 |
2025-08-01 |
Univ California |
Compositions and methods for modulating hair growth
|
|
KR20240017986A
(ko)
|
2017-09-26 |
2024-02-08 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
암 치료를 위한 조성물 및 방법
|
|
CN107721896A
(zh)
*
|
2017-10-19 |
2018-02-23 |
丽珠集团新北江制药股份有限公司 |
一种布瓦西坦的中间体的制备方法
|
|
CN107793342A
(zh)
*
|
2017-10-19 |
2018-03-13 |
丽珠集团新北江制药股份有限公司 |
一种布瓦西坦的制备方法
|
|
BR112020009836A2
(pt)
|
2017-11-30 |
2020-10-13 |
Centurion Biopharma Corporation |
pró-drogas de ligação a albumina de derivados de auristatina e
|
|
IL305268A
(en)
|
2017-11-30 |
2023-10-01 |
Centurion Biopharma Corp |
Maytansinoid-based drug delivery systems
|
|
US11708329B2
(en)
|
2018-01-30 |
2023-07-25 |
The Regents Of The University Of California |
Inhibitors of the WNT/beta-catenin pathway
|
|
CN108147988B
(zh)
*
|
2018-02-13 |
2020-10-02 |
扬州奥锐特药业有限公司 |
一种高手性纯度内酰胺化合物的制备方法
|
|
CN108530402B
(zh)
*
|
2018-04-10 |
2020-06-26 |
浙江工业大学 |
一种(R)-3-丙基-γ-丁内酯的制备方法
|
|
EP3566760A1
(en)
*
|
2018-05-07 |
2019-11-13 |
Universite Libre De Bruxelles |
Method for nucleating crystals from a solution in a capillary tube
|
|
CN112088160B
(zh)
|
2018-05-08 |
2023-07-04 |
Ucb生物制药有限责任公司 |
1-咪唑并噻二唑并-2h-吡咯-5-酮衍生物
|
|
AU2019288382B2
(en)
|
2018-06-19 |
2024-07-25 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
CN110615744B
(zh)
*
|
2018-06-20 |
2023-01-06 |
上海朴颐化学科技有限公司 |
一种布瓦西坦中间体及其制备方法
|
|
US20210122771A1
(en)
|
2018-06-29 |
2021-04-29 |
The Regents Of The University Of California |
New molecular tweezers against neurological disorders and viral infections
|
|
RU2699669C1
(ru)
*
|
2018-07-04 |
2019-09-09 |
Общество С Ограниченной Ответственностью "Валента - Интеллект" |
Новые составы N-карбамоилметил-4-фенил-2-пирролидона
|
|
WO2020023917A1
(en)
|
2018-07-27 |
2020-01-30 |
California Institute Of Technology |
Cdk inhibitors and uses thereof
|
|
ES3066008T3
(en)
|
2018-10-17 |
2026-05-11 |
Univ California |
Prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-ketoisohexanoate, and uses thereof
|
|
EP3699173A1
(en)
|
2018-10-18 |
2020-08-26 |
California Institute of Technology |
Gem-disubstituted pyrrolidines, piperazines, and diazepanes, and compositions and methods of making the same
|
|
EP3873912B1
(en)
|
2018-10-31 |
2026-03-25 |
Intocell, Inc. |
Fused heterocyclic benzodiazepine derivatives and uses thereof
|
|
JP2022510363A
(ja)
|
2018-12-04 |
2022-01-26 |
メティス ファーマシューティカルズ アクチェンゲゼルシャフト |
（ｒ）－２－（２－オキソピロリジン－１－イル）ブタンアミドと（ｓ）－２－（２－オキソピロリジン－１－イル）ブタンアミドを非ラセミ比で含む相乗的組成物
|
|
WO2020176386A2
(en)
|
2019-02-25 |
2020-09-03 |
The Regents Of The University Of California |
Methods of carbon-carbon bond fragmentation
|
|
CN109932442A
(zh)
*
|
2019-03-04 |
2019-06-25 |
成都美域高制药有限公司 |
一种布瓦西坦异构体的检测方法
|
|
EP3947387B1
(en)
|
2019-03-25 |
2024-10-23 |
California Institute Of Technology |
Prmt5 inhibitors and uses thereof
|
|
JP2022534704A
(ja)
|
2019-06-04 |
2022-08-03 |
ヘイガー バイオサイエンシズ，エルエルシー |
オレキシンアンタゴニストとしてのイミダゾロ誘導体、組成物、及び方法
|
|
CN110357752A
(zh)
*
|
2019-08-15 |
2019-10-22 |
中国工程物理研究院化工材料研究所 |
一种快速制备均匀包覆含能材料的方法
|
|
RU2732245C1
(ru)
*
|
2019-08-30 |
2020-09-14 |
Ооо "Валента-Интеллект" |
Новые составы n-карбамоилметил-4-фенил-2-пирролидона для лечения и профилактики ожирения
|
|
CN110551050A
(zh)
*
|
2019-09-02 |
2019-12-10 |
南通大学 |
一种2-[3’-(N-Boc-吡咯基)]-苯甲酸的合成方法
|
|
US10781170B1
(en)
|
2019-10-21 |
2020-09-22 |
Divi's Laboratories Ltd. |
Process for preparing Brivaracetam
|
|
US12649736B2
(en)
|
2019-12-20 |
2026-06-09 |
The Regents Of The University Of California |
Synthesis of compounds to promote hair growth
|
|
WO2021142132A1
(en)
|
2020-01-07 |
2021-07-15 |
The Trustees Of Princeton University |
Compositions and methods for treatment of disease by manipulation of serine metabolism
|
|
WO2021142221A1
(en)
|
2020-01-10 |
2021-07-15 |
The Regents Of The University Of California |
Compositions and methods for the treatment of neurodegenerative diseases
|
|
US20230174460A1
(en)
|
2020-04-21 |
2023-06-08 |
President And Fellowes Of Harvard College |
Afmt analogs and their use in methods of treating parkinson's disease
|
|
LV15614A
(lv)
|
2020-07-30 |
2022-02-20 |
Latvijas Organiskās Sintēzes Institūts |
2-(2-okso-3-pirolin-1-il)acetamīdi kā pretkrampju līdzekļi
|
|
EP4192838A1
(en)
|
2020-08-10 |
2023-06-14 |
Dana-Farber Cancer Institute, Inc. |
Fused tricyclic pyrimidine-thieno-pyridine small molecule inhibitors of ubiquitin-specific protease 28
|
|
EP4192811A1
(en)
|
2020-08-10 |
2023-06-14 |
Dana-Farber Cancer Institute, Inc. |
Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 28
|
|
US20230265082A1
(en)
|
2020-08-10 |
2023-08-24 |
Dana-Farber Cancer Institute, Inc. |
Substituted 1,2,4-oxadiazoles as small molecule inhibitors of ubiquitin-specific protease 28
|
|
CN116782894A
(zh)
*
|
2020-10-06 |
2023-09-19 |
D.E.肖研究有限责任公司 |
作为Kv1.3钾Shaker通道阻断剂的内酰胺化合物
|
|
US20240083839A1
(en)
|
2020-10-07 |
2024-03-14 |
The Regents Of The University Of California |
Compositions and methods for treating neurodegenerative diseases and disorders
|
|
US12570620B2
(en)
|
2020-10-23 |
2026-03-10 |
Dana-Farber Cancer Institute, Inc. |
Covalent inhibitors of creatine kinase (CK) and uses thereof for treating and preventing cancer
|
|
US20240058344A1
(en)
|
2020-12-18 |
2024-02-22 |
Cornell University |
Methods of treating neurodegenerative disorders and stat3-linked cancers using suppressors of electron leak
|
|
WO2022140289A1
(en)
|
2020-12-21 |
2022-06-30 |
Cornell University |
Peptide-linked drug delivery system
|
|
WO2022150574A1
(en)
|
2021-01-08 |
2022-07-14 |
Cornell University |
Inhibitors of mycobacterium tuberculosis lipoamide dehydrogenase
|
|
US11400074B1
(en)
|
2021-02-01 |
2022-08-02 |
Divi's Laboratories Ltd. |
Enzymatic process for the preparation of (2S)-2-[(4R)-2-oxo-4-propyl-pyrrolidin-1-yl]butyric acid and its conversion into brivaracetam
|
|
US12559456B2
(en)
|
2021-02-03 |
2026-02-24 |
Suzhou Brighthope Pharma Tech Co., Ltd |
Method for preparing levetiracetam and intermediates thereof
|
|
US11384050B1
(en)
|
2021-02-03 |
2022-07-12 |
Vitaworks Ip, Llc |
Method for preparing levetiracetam and intermediates thereof
|
|
CN114948953A
(zh)
*
|
2021-06-29 |
2022-08-30 |
四川大学华西医院 |
一种杂原子取代芳香类化合物及其盐的用途
|
|
CN113511994B
(zh)
*
|
2021-08-16 |
2023-03-21 |
江苏八巨药业有限公司 |
一种左乙拉西坦的制备方法
|
|
EP4463462A4
(en)
|
2022-01-14 |
2025-06-25 |
Annexon, Inc. |
COMPLEMENT FACTOR INHIBITORS AND RELATED USES
|
|
CA3252219A1
(en)
|
2022-02-15 |
2023-08-24 |
Rs Oncology, Llc |
THIOStrepton-inspired compounds for cancer treatment and related preparations
|
|
CN114634437B
(zh)
*
|
2022-03-29 |
2023-05-30 |
武汉氟本氘合新材料科技有限公司 |
一种布瓦西坦的简易制备方法
|
|
US11884623B2
(en)
|
2022-05-23 |
2024-01-30 |
Divi's Laboratories Ltd. |
Process for the preparation of (R)-4-propyl pyrrolidine-2-one, a key intermediate for synthesis of brivaracetam
|
|
WO2023250157A1
(en)
|
2022-06-24 |
2023-12-28 |
Cornell University |
Inhibitors of mycobacterium tuberculosis lipoamide dehydrogenase
|
|
JP2025525415A
(ja)
|
2022-07-13 |
2025-08-05 |
アストラゼネカ・アクチエボラーグ |
Ｐｃｓｋ９阻害剤およびその使用方法
|
|
EP4572852A1
(en)
|
2022-08-19 |
2025-06-25 |
Agenebio, Inc. |
Benzazepine derivatives, compositions, and methods for treating cognitive impairment
|
|
EP4582412A4
(en)
*
|
2022-08-31 |
2026-01-21 |
Univ Korea Res & Bus Found |
CHIRAL GAMMA LACTAM DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND ITS METHOD OF PREPARATION
|
|
US20260225046A1
(en)
|
2023-02-02 |
2026-08-06 |
Osmoses Inc. |
Norbornyl benzocyclobutene ladder polymer composite membranes for fluid separation
|
|
CN116041240B
(zh)
|
2023-02-17 |
2024-04-09 |
扬州奥锐特药业有限公司 |
布立西坦中间体的不对称催化氢化合成方法
|
|
EP4431086A1
(en)
|
2023-03-16 |
2024-09-18 |
Adalvo Limited |
Pharmaceutical composition comprising (2s)-2-[(4r)-2-oxo-4-propyltetrahydro-1h-pyrrol-1-yl]butanamide
|
|
US12590059B2
(en)
|
2023-03-28 |
2026-03-31 |
Suzhou Brighthope Pharmatech Co., Ltd |
Process for the production of levetiracetam
|
|
WO2025078883A2
(en)
|
2023-05-06 |
2025-04-17 |
Prepaire Labs Limited |
Organic compound (oxime) to combat chemical warfare agents
|
|
US12528770B2
(en)
|
2023-06-12 |
2026-01-20 |
Suzhou Brighthope Pharmatech Co., Ltd. |
Process for the production of levetiracetam and intermediates thereof
|
|
IL327035A
(en)
|
2023-09-18 |
2026-05-01 |
Flagship Pioneering Innovations Vii Llc |
Ionizable lipidoid compositions and their medical uses
|
|
WO2025072751A1
(en)
|
2023-09-29 |
2025-04-03 |
Battelle Memorial Institute |
Polymer nanoparticle compositions for in vivo expression of polypeptides
|
|
AU2024349841A1
(en)
|
2023-09-29 |
2026-04-09 |
Battelle Memorial Institute |
Polymer nanoparticle compositions for non-viral gene delivery
|
|
KR20260113064A
(ko)
|
2023-11-14 |
2026-07-21 |
플래그쉽 파이어니어링 이노베이션스 Vii, 엘엘씨 |
이온화 가능한 리피도이드 조성물 및 이의 치료적 용도
|
|
WO2025231452A1
(en)
|
2024-05-02 |
2025-11-06 |
Martinez Montemayor Michelle |
Ergosterol peroxide derivatives and uses thereof
|
|
WO2026030679A1
(en)
|
2024-08-01 |
2026-02-05 |
Osmoses Inc. |
Hollow fiber polymer membranes for fluid separation
|
|
WO2026060616A1
(en)
|
2024-09-20 |
2026-03-26 |
Fulcrum Therapeutics, Inc. |
Phenothiazine and phenoxazine calmodulin inhibitors and methods of use thereof
|
|
US20260090998A1
(en)
|
2024-10-02 |
2026-04-02 |
Battelle Memorial Institute |
Methods of using polymer nanoparticle compositions for treating a disease
|
|
WO2026089782A2
(en)
|
2024-10-22 |
2026-04-30 |
Osmoses Inc. |
Process for harvesting helium gas by harnessing greenhouse gas-free geologic hydrogen
|
|
WO2026107178A1
(en)
|
2024-11-13 |
2026-05-21 |
Cornell University |
Global affinity profiling of molecular interactions using competitive enrichment
|